about
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...
Read More
47.98
0.00
(0.00%)
783.7K
XNAS Volume
XNAS 27 Oct, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Tourmaline Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..